New HIV/AIDS Strategy for the US
On 13 th of July 2010 White House had launched the National HIV/AIDS Strategy for United States to address a disease that infects about 56,000 people each year in the United States, with more than 1.1 million Americans currently living with HIV. New US National HIV/AIDS Strategy indicates that access to sterile needles and syringes is a scientifically proven biomedical and behavioral approach that reduces the probability of HIV transmission. The strategy refers to several studies which have found that providing sterilized equipment to injection drug users substantially reduces risk of HIV infection, increases the probability that they will initiate drug treatment, and does not increase drug use. Besides, other studies indicated in the Strategy show that comprehensive prevention and drug treatment programs, including needle exchange, have dramatically cut the number of new HIV infections among people who inject drugs by 80 percent since the mid-1990s.
The legislation changes now allow funding of needle exchange programs domestically, as well as internationally through United States Agency for International Development (USAID) and the President's Emergency Plan for AIDS Relief (PEPFAR), the world's largest single source of HIV/AIDS related funding. Such funding will be available for HIV prevention programs in Eastern European and Central Asian countries where USAID is active. 1
US National HIV/AIDS Strategy - http://aids.gov/federal-resources/policies/national-hiv-aids-strategy/nhas.pdf
|Back to all news|